Chronic lymphocytic leukaemia trials in Germany
8 of 37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
- Where
- Aschaffenburg, Augsburg, Baden-Baden, Bad Liebenwerda, Bad Mergentheim, Bad Reichenhall, Berlin, Bremerhaven, Cologne, Deggendorf, Dresden, Eisenach, Erlangen, Frankfurt am Main, Frankfurt (Oder), Freiburg im Breisgau, Goslar, Hagen, Halle, Hamburg, Hamm, Hanau, Hanover, Hof, Idar-Oberstein, Kaiserslautern, Kassel, Kronach, Landshut, Langenhessen, Lübeck, Magdeburg, Munich, Mutlangen, Neumünster, Neunkirchen, Neuss, Oldenburg, Osnabrück, Paderborn, Porta Westfalica, Potsdam, Regensburg, Rostock, Schwäbisch Hall, Schwetzingen, Stuttgart, Villingen-Schwenningen, Westerstede
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AbbVie
See details and how to joinNCT03342144 - No phaseTaking peopleZanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
- Where
- Lübeck
- Age
- 18 years and over
- People
- 845 worldwide
- Run by
- iOMEDICO AG
See details and how to joinNCT05326308 - No phaseTaking peopleRegistry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
- Where
- Freiburg im Breisgau
- Age
- 18 years and over
- People
- 2,950
- Run by
- iOMEDICO AG
See details and how to joinNCT06043011 - No phaseTaking peopleA Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG
- Where
- Cologne, Ulm
- Age
- 18 years to 99 years
- People
- 2,000
- Run by
- German CLL Study Group
See details and how to joinNCT06792994 - Phase 1Enrolling by invitationLong-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Where
- Berlin, Dresden, Marburg, Munich, Ulm
- Age
- 18 years and over
- People
- 178
- Run by
- AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Essen
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleRegistry of the German CLL Study Group
- Where
- Dresden
- Age
- 18 years and over
- People
- 8,000
- Run by
- German CLL Study Group
See details and how to joinNCT02863692 - No phaseTaking peopleDeveloping a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
- Where
- Berlin, Garmisch-Partenkirchen
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Medical University Innsbruck
See details and how to joinNCT06821880